Australia and New Zealand's Skin Cancer Governance Gap Exposed: 40% of Organisations Never Assessed Workforce Risk Despite 84% Believing Duty of Care Applies
New research reveals a critical blind spot in workplace health and safety…
WAT Medical's EmeTerm Wearable Device Demonstrates Superior Control of Moderate to Severe Postoperative Nausea and Vomiting in JAMA Surgery-Published Clinical Trial
VANCOUVER, BC, Feb. 10, 2026 /PRNewswire/ — WAT Medical is proud to…